General Information of Disease (ID: DIS2XZ0U)

Disease Name Appendiceal neoplasm
Synonyms
vermiform appendix tumour; vermiform appendix tumor; vermiform appendix neoplasm (disease); vermiform appendix neoplasm; tumour of vermiform appendix; tumour of the appendix; tumour of appendix; tumor of vermiform appendix; tumor of the appendix; tumor of appendix; neoplasm of vermiform appendix; neoplasm of the appendix; neoplasm of appendix; appendix tumour; appendix tumor; appendix neoplasm
Definition A benign or malignant neoplasm involving the appendix.
Disease Hierarchy
DISTBY9Z: Tumour
DISV4OKA: Cecal neoplasm
DIS5PNPO: Disorder of appendix
DIS2XZ0U: Appendiceal neoplasm
Disease Identifiers
MONDO ID
MONDO_0001236
MESH ID
D001063
UMLS CUI
C0003614
MedGen ID
1629
SNOMED CT ID
126846004

Drug-Interaction Atlas (DIA) of This Disease

Drug-Interaction Atlas (DIA)
This Disease is Treated as An Indication in 2 Approved Drug(s)
Drug Name Drug ID Highest Status Drug Type REF
Irinotecan DMP6SC2 Approved Small molecular drug [1]
Oxaliplatin DMQNWRD Approved Small molecular drug [2]
------------------------------------------------------------------------------------

Molecular Interaction Atlas (MIA) of This Disease

Molecular Interaction Atlas (MIA)
This Disease Is Related to 1 DOT Molecule(s)
Gene Name DOT ID Evidence Level Mode of Inheritance REF
SATB2 OT2W80XC Strong Altered Expression [3]
------------------------------------------------------------------------------------

References

1 Irinotecan FDA Label
2 Oxaliplatin FDA Label
3 SATB2 protein expression by immunohistochemistry is a sensitive and specific marker of appendiceal and rectosigmoid well differentiated neuroendocrine tumours.Histopathology. 2020 Mar;76(4):550-559. doi: 10.1111/his.14012. Epub 2020 Jan 24.